Hotsia.Com : เที่ยวสะใจ

How does snoring and sleep apnea prevalence differ worldwide overall, what percentage of adults are affected, and how do high-income versus low-income countries compare?

The prevalence of snoring and sleep apnea differs significantly worldwide, with global estimates pointing to a major public health issue. A large number of adults are affected, and there is a notable disparity between high-income and low-income countries, largely driven by differences in lifestyle, demographics, and access to care.

🌎 Snoring and Sleep Apnea Prevalence Worldwide

Snoring is a very common phenomenon, with a high prevalence in the general population. While snoring itself does not always indicate a serious condition, it is a key symptom of obstructive sleep apnea (OSA). Recent epidemiological studies have revealed an astonishingly high prevalence of OSA. A widely cited estimate suggests that approximately 1 billion adults worldwide have obstructive sleep apnea, with a significant proportion having moderate-to-severe disease. The prevalence varies by region, but the overall trend is a high and rising global burden.

The prevalence of OSA in adults is estimated to range from 9% to 38%, depending on the diagnostic criteria used and the population studied. For example, some studies found that OSA affected 22% of men and 17% of women in certain populations, while other research has found even higher rates. A study in Russia found that nearly half of adults between 30 and 70 years old had at least mild OSA. This high prevalence is a major concern as OSA is linked to serious health consequences, including hypertension, heart disease, stroke, and diabetes.

📊 Percentage of Adults Affected

The percentage of adults affected by OSA globally is substantial. Estimates suggest that up to one-seventh of the world’s adult population has some form of OSA. When looking at specific age groups, the numbers are even more striking. Studies show that between the ages of 30 and 70, roughly 26% of people have sleep apnea. The prevalence is also influenced by other factors such as gender, with men being more likely to be affected than women, and age, with prevalence increasing significantly in older populations.

It is important to note that a large number of these cases remain undiagnosed. For example, in the United States, it is estimated that 80-90% of sleep apnea cases go undiagnosed, which means the true global burden is likely much higher than even the staggering current estimates. This underdiagnosis is a critical issue that prevents millions from receiving the necessary treatment to mitigate their health risks.

💰 High-Income vs. Low-Income Countries

The prevalence of snoring and sleep apnea, as well as the related health outcomes, differs between high-income and low-income countries. While early research was primarily concentrated in high-income countries, more recent data highlights a growing burden in low- and middle-income countries (LMICs).

High-Income Countries: In high-income countries, a key driver of the high prevalence of OSA is the rise in obesity rates. Obesity is a major risk factor, and its prevalence has increased dramatically in these regions over the past several decades. Furthermore, lifestyle factors such as sedentary behavior and consumption of high-calorie, low-nutrient foods contribute to the problem. While there is a high prevalence, there is also greater awareness and access to diagnostic and treatment resources, such as polysomnography and CPAP therapy. However, even in these countries, socioeconomic disparities exist, with lower-income individuals having a harder time accessing treatment due to cost and other barriers.

Low-Income Countries: In low-income countries, the prevalence of sleep-disordered breathing is also high and is now increasingly being recognized. While obesity rates are rising, the epidemiology may be influenced by a different set of factors, including anatomical and genetic predispositions, as well as a higher prevalence of infectious diseases that may affect the upper airway. However, a major challenge in LMICs is the near-total lack of access to diagnosis and treatment. The financial cost of a sleep study and a CPAP machine is prohibitive for the vast majority of the population. This means that while the prevalence may be high, the vast majority of cases are undiagnosed and untreated, leading to a greater societal and individual health burden from the associated cardiovascular and metabolic complications. Therefore, while both country types face a high prevalence, the burden of untreated and undiagnosed disease is disproportionately higher in low-income countries.

 

I’m Mr.Hotsia, sharing 30 years of travel experiences with readers worldwide. This review is based on my personal journey and what I’ve learned along the way. I share my experiences on www.hotsia.com